Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $70.52 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie, Inc. | $59.81 | 4 | $0 (2018) |
| Valeant Pharmaceuticals North America LLC | $10.71 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $17.53 | 1 | AbbVie, Inc. ($17.53) |
| 2017 | $52.99 | 4 | AbbVie, Inc. ($42.28) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/12/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $17.53 | General |
| Category: Immunology | ||||||
| 10/13/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Immunology | ||||||
| 08/28/2017 | Valeant Pharmaceuticals North America LLC | MOVIPREP (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $10.71 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/31/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.50 | General |
| Category: Immunology | ||||||
| 05/26/2017 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 18 | 18 | $6,832 | $2,434 |
| 2022 | 2 | 36 | 36 | $10,096 | $3,642 |
| 2021 | 7 | 162 | 170 | $50,107 | $16,623 |
| 2020 | 5 | 103 | 108 | $26,749 | $9,505 |
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 18 | 18 | $6,832 | $2,434 | 35.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 22 | 22 | $8,976 | $3,207 | 35.7% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 14 | 14 | $1,120 | $434.84 | 38.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 49 | 49 | $19,992 | $7,548 | 37.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 18 | 20 | $5,520 | $2,078 | 37.7% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 17 | 17 | $8,517 | $1,831 | 21.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 19 | $3,990 | $1,579 | 39.6% |
| 43235 | Diagnostic examination of esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 15 | 15 | $6,480 | $1,399 | 21.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 21 | 24 | $3,528 | $1,385 | 39.2% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 26 | 26 | $2,080 | $802.88 | 38.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 30 | 30 | $8,280 | $3,258 | 39.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 18 | 18 | $7,344 | $2,933 | 39.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 12 | 12 | $6,012 | $1,270 | 21.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 17 | 19 | $2,793 | $1,117 | 40.0% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 26 | 29 | $2,320 | $926.70 | 39.9% |
About Dr. Charles Catalano, M.D
Dr. Charles Catalano, M.D is a Gastroenterology healthcare provider based in Lynchburg, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750356812.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Charles Catalano, M.D has received a total of $70.52 in payments from pharmaceutical and medical device companies, with $17.53 received in 2018. These payments were reported across 5 transactions from 2 companies. The most common payment nature is "Food and Beverage" ($70.52).
As a Medicare-enrolled provider, Catalano has provided services to 319 Medicare beneficiaries, totaling 332 services with total Medicare billing of $32,204. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Lynchburg, VA
- Active Since 02/22/2006
- Last Updated 07/09/2024
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1750356812
Products in Payments
- Humira (Biological) $59.81
- MOVIPREP (Drug) $10.71
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Lynchburg
Larry Clark, M.d, M.D
Gastroenterology — Payments: $1.3M
Mr. Wei Hou, M.d., Ph.d, M.D., PH.D
Gastroenterology — Payments: $7,735
Ralph Wisniewski, M.d, M.D
Gastroenterology — Payments: $6,349
Robert Richards, M.d, M.D
Gastroenterology — Payments: $4,516
Loretta Maffei, M.d, M.D
Gastroenterology — Payments: $2,537
James Curtiss, Md, MD
Gastroenterology — Payments: $350.87